Related Experiment Videos

[Hormone replacement therapy after breast cancer]

J W Nortier, M Nooy, L Beex

Nederlands Tijdschrift Voor Geneeskunde

|June 17, 1998

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Trade-off preferences regarding adjuvant endocrine therapy among women with estrogen receptor-positive breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: an EORTC phase III study (10863).

European journal of cancer (Oxford, England : 1990)·2006

Early detection of breast and ovarian cancer in families with BRCA mutations.

European journal of cancer (Oxford, England : 1990)·2005

Endocrine treatment options for advanced breast cancer--the role of fulvestrant.

European journal of cancer (Oxford, England : 1990)·2005

Importance of local aromatase activity in hormone-dependent breast cancer: a review.

Breast (Edinburgh, Scotland)·2004

The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'.

Annals of oncology : official journal of the European Society for Medical Oncology·2004

See all related articles